🌟 Join us in welcoming Rajesh Gurjar to the Nivagen family! We're excited to have you on board and look forward to the great things you’ll accomplish. Welcome to the team! #Nivagen #NivagenPharma #NewTeamMember
Nivagen Pharmaceuticals, Inc.
Pharmaceutical Manufacturing
Sacramento, California 8,377 followers
About us
Nivagen is engaged in the development, acquisition and sales of generic prescription drugs and over the counter products for the North American market. Our vision is to deliver high quality products at affordable prices by leveraging global partnerships with the best FDA approved manufacturing facilities across the world. Our sales and marketing personnel are among the best in the world. The US generic prescription market is currently at approximately $60 billion, and over $120 billion's worth of products will be coming off of patent protection in next 10 years. Nivagen believes that, with its strategic partnership model of global alliances with highly efficient pharmaceutical companies across the globe, we can provide cost savings to the consumer while creating value for all members of the supply chain. Nivagen is focused in three areas of product development: development/co-development, acquisition/in-licensing, and providing sales and marketing services. We are actively looking to partner with CRO and CRAM to co-develop products. We are also acquiring existing products. If you are small FDA qualified manufacturer and want to launch your company or product in the US, Nivagen can provide complete turnkey solutions and cost effective delivery on an accelerated timeline.
- Website
-
http://www.nivagen.com
External link for Nivagen Pharmaceuticals, Inc.
- Industry
- Pharmaceutical Manufacturing
- Company size
- 11-50 employees
- Headquarters
- Sacramento, California
- Founded
- 2009
Locations
-
Primary
3050 Fite Circle
suite 100
Sacramento, California 95827, US
Employees at Nivagen Pharmaceuticals, Inc.
-
Minal Belani Singh
GC - Health Law - Community Creator
-
Thomas Henry
Vice President of Sales and Business Development at Nivagen Pharmaceuticals, Inc.
-
Mohammed Taher
Quality Control analyst at Nivagen Pharmaceuticals. Formulation Scientist & Technical Advisor of MFG at BioZone Pharmaceuticals, Inc.
-
Miten Vyasa
Regulatory Affairs/ CMC / US Market / Post Approval RA / Commercial RA / Process Validation, Cleaning Validation & Verification, New Product…
Updates
-
🌟 Join us in welcoming Antara Rath to the Nivagen family! We're excited to have you on board and look forward to the great things you’ll accomplish. Welcome to the team! #Nivagen #NivagenPharma #NewTeamMember
-
-
🌟 Join us in welcoming our new Microbiologists to the Nivagen family! We’re excited to have you all on board and can’t wait to see the great work you’ll accomplish together. Welcome to the team! 👏 #Nivagen #NivagenPharma #NewTeamMembers
-
-
Last week, our Nivagen India team had a wonderful time enjoying the summer weather while bonding over some exciting outdoor adventures! 🌞🧗 #nivagen #nivagenpharma #teambonding
-
-
-
-
-
+2
-
-
🌟 Join us in welcoming Ankit Mehta to the Nivagen family! We're excited to have you on board and look forward to the great things you’ll accomplish. Welcome to the team! #Nivagen #NivagenPharma #NewTeamMember
-
-
🔆We are thrilled to welcome Robert Dream to the Nivagen family! Mr.Robert Dream brings with him a remarkable legacy of over 30 years of leadership in the pharmaceutical, biotechnology, and advanced therapeutics industries. As a Registered Professional Engineer in multiple states, his unmatched expertise, visionary thinking, and deep industry insight are truly invaluable. Throughout his career, Robert has driven innovation across vaccines, ATMPs, oligo/mRNA technologies, and more—always with a strong commitment to collaboration, regulatory excellence, and operational transformation. His leadership extends globally, having guided complex regulatory strategies, managed large-scale capital projects, and shaped best practices through his work with industry organizations like ISPE and PDA. Beyond his technical brilliance, Robert is a mentor, team-builder, and thought leader—consistently championing a culture of excellence and growth. We are excited for the journey ahead with Robert on board and confident that his expertise will further elevate Nivagen’s mission to make a lasting impact in the life sciences space. Welcome aboard, Mr.Robert Dream! #Nivagen #Nivagenpharma #newteammembers
-
-
Wishing everyone a safe and meaningful Fourth of July from all of us at Nivagen Pharmaceuticals! As we celebrate the spirit of independence, we honor the values of freedom, resilience, and innovation that continue to drive progress in healthcare and beyond. Thank you to our dedicated team, partners, and customers for being part of our journey. Happy Independence Day! 🎆 #FourthOfJuly #IndependenceDay #NivagenPharmaceuticals #HealthcareInnovation #ProudlyAmerican
-
-
🌟Celebrating a Successful Facility Review. We are delighted to share that our Nivagen Pharmaceuticals Inc. Duckhorn injectable facility was recently reviewed by Jim Polarine Jr., Principal Consultant, Technical Services at STERIS Corporation. This review represents a wonderful opportunity for our quality-driven manufacturing site to benefit from the guidance of leaders within the industry’s scientific community. We are grateful for the time, expertise, and valuable insights provided. Thank you so much to Jim Polarine and the entire STERIS team for your visit and thoughtful feedback. #Nivagen #Nivagenpharma #steris #steriscorporation #facilityreview #CDMO #injectablefacility
-
-
🌟 Please join us in welcoming our newest team members to the Nivagen family! We’re excited to have you on board and can’t wait to see the impact you’ll make. Welcome aboard! #Nivagen #Nivagenpharma #newteammembers
-
-
A Splash of fun! 🌊 Last Saturday, the Nivagen team had a fantastic time enjoying a Beach Day at Bell Acqua Lake! 🚣♀️ With beautiful weather and a delicious lunch, it was the perfect mix of relaxation, adventure, and team bonding. #TeamNivagen #TeamBonding #CompanyCulture #Nivagen #Nivagenpharma
-
-
-
-
-
+4
-